183 related articles for article (PubMed ID: 24555608)
1. Rate of malignancy in MRI-detected probably benign (BI-RADS 3) lesions.
Spick C; Szolar DH; Baltzer PA; Tillich M; Reittner P; Preidler KW; Pinker-Domenig K; Helbich TH
AJR Am J Roentgenol; 2014 Mar; 202(3):684-9. PubMed ID: 24555608
[TBL] [Abstract][Full Text] [Related]
2. Probably benign breast MRI lesions: frequency, lesion type, and rate of malignancy.
Lourenco AP; Chung MT; Mainiero MB
J Magn Reson Imaging; 2014 Apr; 39(4):789-94. PubMed ID: 24108546
[TBL] [Abstract][Full Text] [Related]
3. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.
Gutierrez RL; DeMartini WB; Eby PR; Kurland BF; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Oct; 193(4):994-1000. PubMed ID: 19770321
[TBL] [Abstract][Full Text] [Related]
4. Histologic work-up of non-palpable breast lesions classified as probably benign at initial mammography and/or ultrasound (BI-RADS category 3).
Gruber R; Jaromi S; Rudas M; Pfarl G; Riedl CC; Flöry D; Graf O; Sickles EA; Helbich TH
Eur J Radiol; 2013 Mar; 82(3):398-403. PubMed ID: 22429299
[TBL] [Abstract][Full Text] [Related]
5. Benign (BI-RADS 2) lesions in breast MRI.
Spick C; Szolar DH; Tillich M; Reittner P; Preidler KW; Baltzer PA
Clin Radiol; 2015 Apr; 70(4):395-9. PubMed ID: 25649442
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of a breast MRI score for the prediction of malignancy of breast lesions detected solely with MRI].
Siegmann KC; Moron HU; Baur A; Hahn M; Vogel U; Claussen CD; Bitzer M
Rofo; 2009 Jun; 181(6):556-63. PubMed ID: 19452398
[TBL] [Abstract][Full Text] [Related]
7. Frequency of Malignancy and Imaging Characteristics of Probably Benign Lesions Seen at Breast MRI.
Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
AJR Am J Roentgenol; 2015 Aug; 205(2):442-7. PubMed ID: 26204298
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of probably benign breast MRI lesions.
Eby PR; DeMartini WB; Gutierrez RL; Saini MH; Peacock S; Lehman CD
AJR Am J Roentgenol; 2009 Sep; 193(3):861-7. PubMed ID: 19696303
[TBL] [Abstract][Full Text] [Related]
9. Frequency of malignancy in lesions classified as probably benign after dynamic contrast-enhanced breast MRI examination.
Sadowski EA; Kelcz F
J Magn Reson Imaging; 2005 May; 21(5):556-64. PubMed ID: 15834907
[TBL] [Abstract][Full Text] [Related]
10. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?
Linda A; Zuiani C; Furlan A; Lorenzon M; Londero V; Girometti R; Bazzocchi M
AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168
[TBL] [Abstract][Full Text] [Related]
11. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up.
Hambly NM; Liberman L; Dershaw DD; Brennan S; Morris EA
AJR Am J Roentgenol; 2011 Jan; 196(1):218-24. PubMed ID: 21178070
[TBL] [Abstract][Full Text] [Related]
12. Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size.
Linda A; Zuiani C; Londero V; Bazzocchi M
Breast; 2008 Feb; 17(1):51-7. PubMed ID: 17709249
[TBL] [Abstract][Full Text] [Related]
13. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
Gökalp G; Topal U
Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of the breast as a problem-solving method: to be or not to be?
Oztekin PS; Kosar PN
Breast J; 2014; 20(6):622-31. PubMed ID: 25200378
[TBL] [Abstract][Full Text] [Related]
15. Clinical indication and patient age predict likelihood of malignancy in suspicious breast MRI lesions.
Gutierrez RL; Demartini WB; Eby P; Kurland BF; Peacock S; Lehman CD
Acad Radiol; 2009 Oct; 16(10):1281-5. PubMed ID: 19733804
[TBL] [Abstract][Full Text] [Related]
16. BI-RADS® 3 lesions at contrast-enhanced breast MRI: is an initial short-interval follow-up necessary?
Bahrs SD; Baur A; Hattermann V; Hahn M; Vogel U; Claussen CD; Siegmann-Luz KC
Acta Radiol; 2014 Apr; 55(3):260-5. PubMed ID: 23969262
[TBL] [Abstract][Full Text] [Related]
17. Follow-up frequency and compliance in women with probably benign findings on breast magnetic resonance imaging.
Marshall AL; Domchek SM; Weinstein SP
Acad Radiol; 2012 Apr; 19(4):406-11. PubMed ID: 22227041
[TBL] [Abstract][Full Text] [Related]
18. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
Pediconi F; Padula S; Dominelli V; Luciani M; Telesca M; Casali V; Kirchin MA; Passariello R; Catalano C
Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
[TBL] [Abstract][Full Text] [Related]
19. Breast MRI in the evaluation of locally recurrent or new breast cancer in the postoperative patient: correlation of morphology and enhancement features with the BI-RADS category.
Seely JM; Nguyen ET; Jaffey J
Acta Radiol; 2007 Oct; 48(8):838-45. PubMed ID: 17851971
[TBL] [Abstract][Full Text] [Related]
20. Effect of preoperative breast magnetic resonance imaging on surgical decision making and cancer recurrence rates.
Pediconi F; Miglio E; Telesca M; Luciani ML; Kirchin MA; Passariello R; Catalano C
Invest Radiol; 2012 Feb; 47(2):128-35. PubMed ID: 21934515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
